Center for Autism and Related Disorders, LLC (“CARD”) and four of its affiliates in their Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas. CARD is one of the nation’s largest treatment providers for individuals diagnosed with autism spectrum disorder. Prior to filing for Chapter 11, CARD entered into a stalking horse asset purchase agreement for a going-concern sale of substantially all of CARD’s assets. CARD intends to use the Chapter 11 cases to run a competitive sale and bidding process to maximize enterprise value. CARD entered the Chapter 11 cases with a new money, delayed draw term loan debtor-in-possession financing facility from the company’s prepetition credit facility lenders.
Envision Healthcare Corp. and 216 of its affiliates in the commencement of pre-arranged Chapter 11 cases. Envision is a leading national medical group that employs or partners with more than 21,000 clinicians and provides care to patients across the U.S., with nearly 30 million patient visits each year. The two restructuring support agreements contemplate a collective deleveraging of approximately $7.4 billion of secured and unsecured debt and the separation of Envision’s physician services and ambulatory surgical center businesses.
TJC in its sale of Worldwide Clinical Trials to Kohlberg & Company.
Bain Capital Insurance in its investment in Aptia, a provider of employee benefits and pensions administration service.
Waters Corporation in its $1.36 billion acquisition of Wyatt Technology.
Zelis in its acquisition of PaySpan.
SK Capital in its acquisition of Apotex, a pharmaceutical company that produces affordable medicines.
Zelis, a portfolio company of Parthenon Capital, in its acquisition of Payer Compass.
TA Associates in its investment in Intelerad.
EW Healthcare Partners in its proposed $177 million acquisition of TherapeuticsMD (NASDAQ: TXMD), a women's healthcare company.
Millennium Trust in its acquisition of PayFlex from CVS Health.
PathGroup in its majority investment from GTCR.
SpendMend, a portfolio company of Sheridan Capital Partners, in its sale to Morgan Stanley Capital Partners.
Owens & Minor, Inc. in its $1.6 billion acquisition of Apria, Inc.
Arsenal Capital Partners in its merger and acquisition of Autism in Motion Clinics, Inc.
Cinven in its merger and acquisition of BALX Holdings, LLC and BioAgilytix.
